Leveraging Innovative Strategies for Speedy Cell Line Development
On-demand Webinar
Cell line development (CLD) involves the derivation of clones from single cells and screening thousands of these clones to find those that are stable, high-producing, and that exhibit desired critical quality attributes (CQAs). Any misstep during this critically important phase can jeopardize the path to product commercialization.
Learn how the incorporation of innovative technologies such as automated systems and high-throughput analytical screening tools can eliminate bottlenecks in clone selection, fast-track development timelines and reduce the cost per experiment in this on-demand webinar.
This roundtable discussion features industry experts discussing technologies, best practices and strategies for delivering robust, stable, high-yielding cell lines to accelerate and streamline the drug discovery process.
View this webinar to learn about:
- The importance of identifying high-performing cell lines early in the development process
- Analytical tools and techniques to optimize cell line development and selection workflows
- Accelerating your path to commercialization while minimizing risks
Raja Srinivas, Ph.D.
Co-Founder
Asimov
In 2017, Raja Srinivas cofounded Asimov, a biotech startup that brings together synthetic biology with machine learning and automation to advance the design and manufacture of biologics and gene therapies.
Raja received his undergraduate degree at Johns Hopkins University and his doctorate at MIT.